Roche to Expand Diabetes Sector

Following reports of Johnson & Johnson selling their diabetes division, Roche has announced plans to expand and innovate their diabetes business. This innovation comes with plans to partner with smaller companies to offer more device options. Roland Digglemann,...

Trump Confirms Medicare Drug Price Negotiations

After meeting with drug makers last week, President Trump has returned to his former claim of Medicare drug negotiations. In a Tuesday morning press brief, Whitehouse Spokesman, Sean Spicer, claimed that, yes, Trump is a proponent of Medicare negotiations. This claim...

Tarveda Raises Phase 2 Funding of Pentarin

Tarveda Therapeutics has gained $30 million in funding for Pentarin second phase clinical trials through new investor, Versant Ventures. The funding will enable the pharmaceutical company to continue developing the newest cancer treatment which combines tumor...

Trump Meets Pharma Executives Over Drug Pricing

Trump Meets Pharma Executives Over Drug Pricing “Lower drug prices,” ordered President Donald Trump in a Tuesday morning meeting with pharmaceutical executives. The meeting, attended by many pharmaceutical giants like Amgen, Lily, and PhRMa members, also included...

Mylan, Teva Agree to $96.5M Settlement

A decade after the suit was filed claiming pharmaceutical companies Mylan and Teva conspired to stall generic narcolepsy medication Provigil, a settlement has been reached. Plaintiffs in the suit argued that the companies engaged in “unlawful reverse payment...

FDA Hiring Freeze Slowing Drug Approval, Raising Drug Prices

For the past week, the FDA has been on hold. At the end of 2016, the agency had over 700 vacant positions in its drug department, and more to come with the 21st Century Care Act. The hiring freeze is stopping the agency from working within its usual restricted...